Fairs, Conferences and Events

Join our User Group Meetings or visit us at fairs to learn more about our scaffold-free 3D microtissues

Join one of our User Group Meetings and become fully updated on 3D-cell-culture technologies or visit our booth and see our scientific presentations at one of the many international fairs, conferences and events in which we participate.  We look forward to meeting you!

03-04.10.2017 - ELRIG Drug Discovery 2017

Oral Presentations | In-booth Posters



ELRIG2017 3DInSight 2 01

Bring safer, better drugs to market faster with InSphero

Learn more about how InSphero microtissue technology is helping the world's largest pharmaceutical companies develop safer, more effective drugs with our advanced 3D models for drug safety and efficacy testing. Our team will be in Liverpool giving both oral and poster presentations on the latest advances in 3D cell based assays, disease models, and microphysiological systems. Visit Booth C4 to view our in-booth poster hall and learn more about:


Conference Date

October 3-4, 2017


ACC, Liverpool, UK


Oral Presentations

A Microphysiological System
Built for 3D Microtissue Spheroids

Presented by Dr. Olivier Frey, InSphero AG
Tuesday, Oct 3, 11:30–Noon, Room 3 | Poster Hall


Bridging the in vitro/in vivo gap in drug development with
standardized 3D models

Presented by Dr. Frank Junker, InSphero AG 
Wednesday, Oct 4, 9:45-9:55, Hall 1B


In-booth Posters

A Robust In Vitro Islet Model: Long-lived, Standardized
and Glucose-responsive Human Islet Microtissues

Islet Poster Thumbnail
Use of 3D InSight™ Liver Microtissues for Drug Safety Assessment from Early Hepatotoxicity Screening to Mechanistic Investigations

LiMT Poster Thumbnail

20-24.10.2017 - AASLD - The Liver Meeting

Presentation Schedule | Anti-fibrotic drug discovery | DILI Prediction


AASLD2017 banner



Accelerate anti-fibrotic drug discovery with the 3D InSight™ Human Liver Fibrosis Modelfibrosis model

At AASLD 2017, you'll have an opportunity to learn about a powerful new 3D cell-based model for for studying mechanisms of fibrosis induction and in vitro screening of anti-fibrotic drug efficacy.

  • Rely on a physiologically relevant model commposed of primary human hepatocytes, hepatic stellate cells, kpffer cells, and liver endothelial cells
  • Expand your assay window with a pre-qualified model that exhibits pro-fibrotic marker induction reflecting the in vivo disease state
  • Perform reproducible, throughput-compatible anti-fibrotic drug screening using a standardized assay-ready model system

InSphero Liver Microtissue Product Manager Dr. Radina Kostadinova will be presenting compelling data generated using the 3D InSight™ Human Liver Fibrosis Model during the Basic Fibrosis Research and Stellate Cell Biology poster session on Friday, October 20. She and Field Application Scientist Judi Wardwell will be available throughout The Liver Meeting to discuss how you can leverage this advanced 3D model in your anti-fibrotic drug discovery research.   

This email address is being protected from spambots. You need JavaScript enabled to view it.


Your 3D InSight™ Conference Planner

Conference Dates
October 20-24, 2017

Walter E. Washington Convention Center, Washington, DC  USA

AASLD Program-at-a-Glance

Poster Presentation

Friday, October 20, Presented 12:00 - 1:30 PM
Poster abstract #385: Development and characterization of a novel in vitro human liver fibrosis model for efficacy testing of anti-fibrotic drugs based on 3D Human Liver Microtissues

Poster Session I: Basic Fibrosis Research and Stellate Cell Biology |  8:00 AM - 5:30 PM

AASLD poster

Radina 01

24.10.2017 - Promega Day 2017

Promega Day

Join InSphero at Promega Day 2017 in Rome

      24.10.2017 - Promega Day 2017


Promega Day 2017 is a unique opportunity to meet Promega Scientists and Italian Researchers to discuss challenging projects and innnovative techniques.
      Hotel Universo (map)
   via Principe Amedeo 5B
           00185 Rome
  Dr. Tomas Hejhal - InSphero AG (CH): 12:20- 12:50


Utilizing spherical human microtissues for evaluation of drug efficacy and safety


 MG 0969
Event Website & Registration: promega.com

20 - 24.08.2017 - 10th World Congress - Alternatives and Animal Use in the Life Sciences


Discover the 3Rs of InSphero 3D InSight™ Microtissue Platforms

Relevance. Robustness. Reproducibility.

Visit InSphero at the 10th World Congress in Seattle to learn how our advanced 3D microtissues are raising the bar with physiologically relevant in vitro models that can help reduce the use of in vivo animal studies in drug discovery and development.  

  • Relevant – using primary human-derived cells, our liver, islet and tumor models enables in vitro efficacy and safety studies that are more predictive of the in vivo response in humans
  • Robust – culturing primary cells in a scaffold-free 3D format results in more in vivo-like tissue structure and functionality, and extends the in vitro longevity of the model, allowing for long-term, repeat dose drug exposure studies
  • Reproducible – our 3D Select™ Process and patented 96-well assay platform ensure unrivaled physiological robustness, with the consistency and automation-friendly assay formats to meet industry-scale screening demands 


Raising the bar for improved physiological relevance

Achieve DILI prediction with 2X the sensitivity of 2D PHH assays

AZ Gen Paper thumb 01AstraZeneca and Genentech put 3D InSight™ Human Liver Microtissues to the test against 110 clinically defined DILI compounds. Read the summary of the landmark Archives of Toxicology 2017 paper and download it for your summer science reading list.




Investigate mechanisms of toxicity with our new in vitro 3D monkey liver model

3D InSight Monkey Liver MicrotissuesNow you can translate and troubleshoot hepatotoxicity detected in in vivo cynomolgus monkey studies using an in vitro 3D monkey liver model.  3D InSight™ Monkey Liver Microtissues are an organotypic co-culture of primary cynomolgus hepatocytes retaining the advanced, integrated biology required for species-specific studies in investigative toxicology. Visit booth 407 to learn more! 



Accelerate diabetes drug discovery with standardized pancreatic islet microtissues

3D InSight™ Islet Microtissues are uniform, functionally robust, and long-lived primary islets delivered pre-qualified and assay-ready for studying islet function, regeneration and preservation.  Gain 13-fold glucose-responsive insulin secretion in a highly reproducible primary human model that eliminates tedious hand-picking!  View our islet poster presentation.


Your 3D InSight™ Conference Planner

Conference Dates
August 20-24, 2017

Washington State Convention Center, Seattle, WA  USA


View the 10th WC Online Program

  Oral Presentations

Exhibitor Hosted Session

Thursday, August 24, 10:00 - 10:15 AM, Room 608 (Program Number III-4-191)
In vitro skin microtissue model for toxicology and efficacy testing

Product Manager Simon Strobel

Presented by Dr. Simon Ströbel, InSphero AG


Poster Presentations


Time TBD
Abstract 230: GravityFLOW: A Microtissue-based Multi-tissue Platform
Presented by Dr. Lei He

InSphero xspecies Posters at SOT 2017

Time TBD
Abstract 339: A robust In Vitro Islet Model: Long-lived, Standardized, and Glucose-responsive Human Islet Microtissues
Presented by Dr. Sue Grepper

09-13.06.2017 - ADA - 77th Scientific Sessions


Join InSphero at ADA in San Diego, CA. Booth #113

09-13.06.2017 - ADA - 77th Scientific Sessions

Poster Presentations | Promotions | Video

PiMT header 02 01

InSphero will present groundbreaking research featuring the use of our award-winning 3D InSight™ Islet Microtissues as a more reliable, robust, and efficient in vitro islet model for diabetes drug discovery.  View our poster session or visit us at Booth #113 to learn more about how our long-lived model brings greater reproducibility and physiological relevance to in vitro assays for:

  • β-cell function and insulin secretagogues
  • α-cell function and glucagon suppressors
  • Islet viability and apoptosis
  • β-cell proliferation
  • Type I & Type II disease modeling
  • Dynamic insulin secretion (see our ADA poster 2202-P)
  • Drug-induced pancreatic endocrine injury

Watch this video to find out how our 3D InSight™ Islet Microtissues are transforming islet research.

Conference Date
June 09-13  2017
111 Harbor Dr.
San Diego, CA 92101, USA

Enter to Win a Fitbit!  The combined power of InSphero 3D InSight™ Islet Microtissues and ALPCO Stellux® Chemi Insulin ELISA Kits can help you gain greater biological InSights for diabetes drug discovery. Visit the InSphero (Booth 113) and ALPCO (Booth 1649) booths to learn more about our 3D-optimized GSIS protocol, and get registered to win a Fitbit. Print the PDF entry card or pick one up at either booth, then get your entry stamped at both booths for your chance to win!        

Fitbit webALPCO blue gray logo

Sunday is "Wear Red" Day!  Visit us at Booth #113 to get your "Friends don't let friends hand-pick islets" button.  It's a great way to show your support for diabetes research...and our primary human islet format that's 6X more efficient than hand-picking.  

 InSphero Islet Button ADA

Poster Presentation (Sun) and Moderated Discussion (Mon):

2202-P Using Uniform Reaggregated Pancreatic Islets in a Microfluidic Perifusion System Enables Studying Insulin Release Dynamics at Single-Islet Level
In collaboration with ETH Zurich


Presented by Dr. Burcak Yesildag, InSphero AG


Presentation Details:

Session Type: General Poster Session
Session Title: 23-C Islet Biology - Beta Cell Stimulus-Secretion Coupling and Metabolism
Session Date/Time: Sunday Jun 11, 2017 12:00 PM - 1:00 PM

Session Type: Moderated Poster Discussion
Session Title: Insulin Secretion and Signaling
Session Date/Time: Monday Jun 12, 2017 12:00 PM - 1:00 PM

15.06.2017 - 26th PhD Students Symposium of the CRBM


Join InSphero at 26th PhD Student Symposium of the CRBM in Montpellier.

15.06.2017 - 26th PhD Students Symposium of the CRBM

The PhD Students Symposium is an annual event which is a unique opportunity for students to share their work with all the members of the CRBM . This year, it will take place in the Campus de Saint-Priest on the 15th of June 2017. We are looking forward to seeing you all there.

Conference Date
                    June 15  2017
                   Université Montpellier II
                   Campus de Saint-Priest
                      860 Rue St - Priest
                  34090 Montpellier, France



24 - 27.06.2017 - EACR-AACR-SIC Special Conference 2017



                                                                               Join InSphero at #EAS17 

24 - 27.06.2017 - EACR-AACR-SIC Special Conference 2017

Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR) and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 will build on the success of the previous conference, which was widely praised for the quality of its programme and inspirational contributions.

The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort.



Conference Date
24 - 27 June, 2017
                           Firenze Fiera
 Piazza Adua 1, 50123 Florence, Italy (Map)

14 - 17.05.2017 - ESACT Meeting in Lausanne



Join InSphero at ESACT Booth #39


14 - 17.05.2017 - ESACT Meeting in Lausanne

The scientific committee is preparing a highly informative programme under the following meeting theme: Cell technologies for innovative therapies. The meeting is organised at the heart of one of the most innovative regions in the field of biomedical research. The conference venue is located within the campus of the EPFL, a university which ranks among the best institutions worldwide and has a very strong focus in life sciences. In short, this is a great place for innovation and certainly a great place to hear about innovation and learn about the latest advances in our field.



Conference Date
14 - 17 May, 2017
EPFL | École polytechnique fédérale de Lausanne
Route Cantonale, 1015 Lausanne, Switzerland (Map)



  Poster Presentations


Monday May 15 from 14:00 to 15:30
Poster 0361: Integrating an in vitro-based therapeutic index into phenotypic drug discovery apporoaches

Where: ESACT, Exhibition Hall

Jens M Kelm

Presented by Dr. Jens Kelm, InSphero AG


Monday May 15 from 14:00 to 15:30
Poster 0377: Assessment of mitochondrial activity in 3D human liver microtissues as a tool for mechanistic investigations of adverse drug effects
Where: ESACT, Exhibition Hall

SMe SOT2017 InSphero Microtissue Presentation

Presented by Dr. Simon Messner, InSphero AG


Tuesday May 16 from 14:00 to 15:30
Poster 0372: Characterization and application of 3D multi-donor human liver microtissues for predictive DILI testing and mechanistic investigations
Where: ESACT, Exhibition Hall


Presented by Dr. Radina Kostadinova, InSphero AG


Oral Presentation


Monday May 15 from 05:30 PM to 06:30 PM
Title: A novel in vitro pancreatic islet model system for diabetes research

Where: ESACT, Session Room: Auditorium A


Presented by Dr. Burcak Yesildag, InSphero AG

Tuesday May 16 from 09:00 to 10:30
Title: Automation-compatible microfluidic system for multi-tissue integration

Where: ESACT, Session Room: Auditorium A

Olivier Frey

Presented by Dr. Olivier Frey, InSphero AG

10 - 11.05.2017 - Advances in Cell Based Screening 2017 #ELRIGCBS17


 Advances in Cell Based Screening

Join InSphero at ELRIG Booth #11


10 - 11.05.2017 - Advances in Cell Based Screening 2017

The 2nd ELRIG bi-annual conference on Advances in Cell Based Screening in Drug Discovery will be held on the 10th and 11th of May 2017 at AstraZeneca in Gothenburg.

Topics include:

  • Advanced cellular models
  • Omics for screening and profiling
  • Target engagement and deconvolution
  • Applied phenotypic screens

Speakers from leading laboratories, both academic and industrial, will present and discuss the latest updates and advances in cellular systems and drug discovery platforms. Throughout the two-day conference, there will be exclusive opportunities to network with scientists and researchers from the pharmaceutical, academic and vendor communities and be involved in inspiring and interesting discussions on challenges and solutions relating to current and breakthrough assay technologies.

Come and talk to us at booth #11!



Conference Date
10 - 11 May, 2017

Pepparedsleden 1
   43153  Mölndal
       Sweden     (Map)



  Snapshot Presentation


Wednesday, May 10, 15:00 pm

 Presented by Dr. Tomas Hejhal, InSphero AG



Poster Presentation


Thursday,  May 11 from 17:00 to 18:30 pm

Poster: A Robust In Vitro Islet Model: Long-lived, Standardized and Glucose-responsive Human Islet Microtissues

Presented by Dr. Adrian Rea, InSphero AG

15-17.05.2017 - Applied Pharmaceutical Toxicology 2017


Join InSphero at APT in San Francisco, US.

15-17.05.2017 - Applied Pharmaceutical Toxicology 2017

  Conference Date
  May 15-17  2017
                    Gentech Building 35
                       Upper Campus
                       350 DNA Way
          South San Francisco, CA 94080


Poster Presentation:
3D tumor/stroma co-culture spheroid models for immuno-oncology applications

         Presented by Lei He, InSphero Inc. 


19 - 23.04.2017 - EASL: The International Liver Congress 2017


Join InSphero at EASL in Amsterdam.  #ILC2017

19 - 23.04.2017 -  EASL:  The International Liver Congress  2017

The International Liver Congress™ (ILC) is the annual meeting of the European Association for the Study of the Liver. It is held in April every year. The next ILC will take place in Amsterdam, The Netherlands, 19-23 April 2017.

  Conference Date
19 - 23 April, 2017
RAI Congress Centre, Amsterdam
Europaplein 2, 1078 GZ Amsterdam, Niederlande (Map)

        View the Conference Program


Poster Presentation: April 22
Poster SAT-455: A novel 3D Liver Microtissue Model for studying steatosis in vitro

SMe SOT2017 InSphero Microtissue Presentation

         Presented by Dr. Simon Messner, InSphero AG


01 - 05.04.2017 - American Association of Cancer Research (AACR) 2017 Annual Meeting



Accelerate oncology drug discovery and development

With physiologically relevant tumor models that reflect in vivo complexity

InSphero tumor microtissue model reflected
Visit InSphero at the AACR 2017 Annual Meeting to learn how our 3D InSight™ Oncology Services can help you accelerate development of anti-cancer drugs and immuno-therapeutic strategies, using 3D tumor spheroid models that more accurately reflect the complex biology of tumor microenvironments. We'll also be previewing our new GravityTRAP™ 384 Microtissue Platform, a first-of-its-kind 384-well platform for high-throughput and high content imaging designed and optimized specifically for use with spheroids. Visit one of our posters, or join us at Booth 1029 to browse our in-booth poster hall.





What's New at AACR 2017

3D InSight™ Immuno-oncology

Assess immune cell infiltration and tumor cell killing in vitro

The InSphero 3D InSight™ Oncology Services team can guide you through preclinical in vitro evaluation of your immuno-therapeutics in physiologically relevant 3D tumor microtissues.  Our 3D experts can build complex tumor spheroid models comprised of tumor, stromal, and immune components with the reproducibility required to ensure assay consistency and confidence in data interpretation.   

Potential applications include:  

  • Immune cell infiltration
  • Tumor cell killing
  • Checkpoint inhibitor efficacy
  • Mono-or multi-specific antibody efficacy
  • Immuno-modulator activity

InSphero immuno oncology applications


Sneak Peek:  GravityTRAP™ 384 Microtissue Platform

Achieve superior HCI in 3D tumor spheroids 
384Well overview 01
At AACR 2017, we'll be previewing our new GravityTRAP™ 384 Microtissue Platform, a spheroid-optimized high-throughput format for tumor microtissues compatible with today's state-of-the-art liquid handling and high content imaging systems. You'll soon be able to harness the benefits of working in more physiologically relevant 3D tumor spheroid models without the fear of aspirating your microtissues and with a flat glass base plate for superior imaging. Watch the video then stop by our booth to learn more.   





Your 3D InSight™ Conference Planner

Conference Dates
April 1-5, 2017

Walter E. Washington Convention Center, Washington, DC  USA


Download the AACR Meeting App
View the AACR Online Meeting Planner

  Poster Presentations

See how the InSphero 3D Select™ Process is being applied to personalized therapeutic approaches for cancer

Wednesday April 5, 8:00 AM - 12:00 PM
5781/17 (Section 38): Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy

SDh rd 01

Presented by Dr. Sumeer Dhar, InSphero AG in collaboration with University of Zurich


Wednesday April 5, 8:00 AM - 12:00 PM
5780/16 (Section 38): 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictors for clinical outcome of personalized chemotherapy

Presented by Cheng-guang Wu, University of Zurich

In-booth Poster Hall

AACR2017 booth poster insphero oncology platform

Accelerate Drug Discovery and Development with InSphero’s Oncology Platform

AACR2017 booth poster immuno oncology

Evaluate efficacy of immuno-therapeutics in biologically relevant 3D cancer microtissue models

AACR2017 booth poster NCATS phenotypic screening

Multi-parametric 3D tumor microtissue-based phenotypic compound classification

AACR2017 booth poster tumor relapse

Assessment of tumor recurrence with an in vitro 3D tumor microtissue model


29 - 30.03.2017 - Research & Innovation 2017 #ELRIG 17

ResearchInnovation ELRIG17

Join InSphero at Research & Innovation in Cambridge.  #ELRIG2017

29 - 30.03.2017 -  Research & Innovation 2017 #ELRIG 17

The meeting will bring together world class speakers and leading academic and industry experts who will discuss the challenges and opportunities for cells as models of disease to improve the success of drug discovery and to develop new therapeutic agents. Hear up-to-date views on this exciting and rapidly evolving area, including presentations on the latest advances and technology breakthroughs.

  Conference Date
29 - 30 March, 2017
Homerton College, Cambridge, UK 
Hills Road, Cambridge CB2 8PH (Map)

View the Conference Program
Poster Presentation:
A three-dimensional ex vivo platform for assessing targeted immunotherapeutic agents

19 - 23.03.2017 - Keystone Symposia: Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7)

Keystone Symposia K1

Join InSphero scientist Sumeer Dhar at our poster presentation

Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7)

The meeting will begin on Sunday, March 19 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 23 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. 

Conference Date
19 - 23 March, 2017

Fairmont Chateau Whistler, Whistler, British Columbia

View the Conference Program

A three-dimensional ex vivo platform for assessing targeted immunotherapeutic agents
Francesca Chiavarro, Tamara Tanos, Irina Agarkova, Lei He, Jens Kelm, Patrick Guye, Sumeer Dhar (presenter)


19 - 23.03.2017 - Keystone Symposia: Injury, Inflammation and Fibrosis (C8)

Keystone Symposia K1

Join InSphero FAS Sue Grepper at our poster presentation

Injury, Inflammation and Fibrosis (C8)


Conference Date
26 - 30 March, 2017

Snowbird Resort, Snowbird, UT, USA

View the Conference Program



A novel 3D liver microtissue model for studying steatosis in vitro
Fabrice Muller, Tobias Strassfeld, Simon Messner, Radina Kostadinova, Sue Grepper (presenter), Wolfgang Moritz, David Fluri


Fairs, Conferences and Events Archive

Company video